5Misra A,Peethambaram A,Garg A.Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy:Report of 35 cases and review of the literature[J].Medicine,2004,83:18-34.
6D'Amico G,Ferrario F.Mesangiocapillary glomerulo nephritis[J].J Am Soc Nephrol,1992,2:S159.
7Little MA,Dupont P,Campbell E,et al.Severity of primary MPGN,rather than MPGN type,determines renal survival and post-transplantation recurrence risk[J].Kidney Int,2006,69:504-511.
8Braun MC,Stablein DM,Hamiwka LA,et al.Recurrence of membranoproliferative glomerulonephritis type Ⅱ in renal allografts:The North American Pediatric Renal Transplant Cooperative Study experience[J].J Am Soc Nephrol,2005,16:2225-2233.
9West CD.Childhood membranoproliferative glomerulonephritis:An approach to management[J].Kidney Int,1986,29:1077-1093.
10Tarshish P,Berstein J,Tobin J,et al.Treatment of mesangiocapi1lary glomerulonephritis with alternate-day prednisone:A Report of the International Study of Kidney Disease in Children[J].Pediatr Nephrol,1992,6:123.
